APX 2041
Alternative Names: APX-2041; APX-2104Latest Information Update: 29 Apr 2021
At a glance
- Originator Amplyx Pharmaceuticals
- Class Antifungals
- Mechanism of Action GWT1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Aspergillosis